Jubilant Pharmova (Previously Jubilant Life Sciences)

(CNN)The US government in coordination with Eli Lilly said it will no longer distribute the Covid-19 monoclonal antibody therapy bamlanivimab for use on its own. The halt is due to the “sustained increase” in coronavirus variants in the United States.

Bamlanivimab can still be used with etesevimab, another monoclonal antibody treatment developed by Eli Lilly. In combination, the two Eli Lilly treatments seem to work against coronavirus variants.

Lilly is currently working with Amgen to scale up the manufacturing of etesevimab

1 Like